IOLCP212.00

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersMOREPENLABFDCINNOVACAPORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹6,223 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment921.61,158.41,165.41,165.4
+ Capital Work-in-Progress99.820.893.693.6
+ Investment Property17.4
+ Other Intangibles11.612.312.812.8
+ Intangibles under Development1.01.11.91.9
+ Non-current Investments0.017.417.417.4
+ Other Non-current Financial Assets48.97.945.145.1
Non-current Financial Assets48.925.362.562.5
+ Other Non-current Assets24.412.823.123.1
Total Non-current Assets1,124.61,230.71,359.31,359.3
Current Assets
+ Inventories424.8360.6371.1371.1
+ Current Investments2.93.33.53.5
+ Trade Receivables471.2513.7603.1603.1
+ Cash & Cash Equivalents7.778.265.465.4
+ Other Bank Balances135.2130.0133.0133.0
+ Other Current Financial Assets7.15.67.57.5
Current Financial Assets624.1730.8812.5812.5
+ Other Current Assets64.159.644.144.1
Total Current Assets1,119.81,151.31,227.61,227.6
Total Assets2,244.42,382.12,587.02,587.0
Equity
+ Equity Share Capital58.758.758.758.7
+ Other Equity / Reserves1,552.81,629.01,739.81,739.8
Equity — Owners of Parent1,611.51,687.71,798.61,798.6
Total Equity1,611.51,687.71,798.61,798.6
Liabilities
+ Other Non-current Financial Liab0.02.42.4
Non-current Financial Liabilities0.00.02.42.4
+ Provisions — Non-current6.76.711.011.0
+ Deferred Tax Liabilities66.177.884.984.9
+ Other Non-current Liabilities0.0
Non-current Liabilities72.984.598.298.2
+ Borrowings — Current32.8117.0132.0132.0
+ Trade Payables469.2427.6482.6482.6
+ Other Current Financial Liab37.846.351.851.8
Current Financial Liabilities539.7590.9666.3666.3
+ Provisions — Current3.42.03.43.4
+ Current Tax Liabilities0.02.42.4
+ Other Current Liabilities16.917.118.118.1
Current Liabilities560.0609.9690.2690.2
Total Liabilities632.9694.4788.4788.4
Total Equity & Liabilities2,244.42,382.12,587.02,587.0
Assets — additional as-filed lines
+ Current Tax Assets6.80.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current6.77.37.3
+ Dues to Other Creditors — Current420.8475.3475.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.